Liquid Biopsy
FMI Empowers its Genomic Cancer Testing by Licensing TwinStrand’s Duplex Sequencing Technology
2020-11-18
Foundation Medicine’s Liquid Biopsy Test Bags FDA Approval for Eighth Indication as Companion Diagnostic
2020-11-10
FMI’s Liquid Biopsy Test Adds 3 Companion Diagnostic Indications for Advanced Ovarian, Breast and Lung Cancers
2020-10-30
Exact Sciences Looks to Thrive in Blood-Based, Early Cancer Detection Space with Two New Buyouts
2020-10-29
Foundation Medicine Fortifies Growing Prominence in Liquid Biopsy Space by Acquiring Lexent Bio
2020-06-15
2019 Asia-Pacific Extracellular Vesicles Conference Made the World-leading Experts Gathered in Taipei
2019-01-19
Genomics in Prostate Cancer and Beyond: Interview with Dr. Colin Collins, Senior Scientist at the Vancouver Prostate Centre
2018-10-30
LATEST
Medicare Part D Enrollment Data for 2026 Shows 83% of Seniors in Plans with Preferred Pharmacy Networks
2026-04-15
Hybrid Hub Models on the Rise as 2026 Patient Services Report Highlights Technology Gaps and Interoperability Challenges
2026-04-15
Mark Cuban Comments on FTC Settlement with Express Scripts Amid 340B Program’s Role in Hospital Consolidations
2026-04-15
Pharmaceutical Experts Advocate for Flexible Hybrid Models to Replace One-Size-Fits-All DTP Programs
2026-04-15
The Targeted Strike – ADCs and Bispecifics Delivering Precision Payloads in Modern Oncology
2026-04-15
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California





